Advertisement

cancer talk

  • Practical Considerations for Cannabis

    People with cancer who are thinking about using cannabis to manage cancer-related symptoms should seek answers to some practical questions.

    by Kate Yandell

  • An Emerging Treatment for Metastatic Prostate Cancer

    A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.

    by Pamela Rafalow Grossman

  • Exercise, Cancer and Aging

    A study on aging shows that cancer survivors are at higher risk of losing strength and walking more slowly compared to those with no cancer history. Exercise is one way to combat this decline.

    by Marcus A. Banks

  • Preconceived Notions: Cancer, Fertility Coverage and the Law

    Insurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state.

    by Shelly Rosenfeld

  • Drug Delays Recurrence in People With Early-Stage Breast Cancer

    People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.

    by Pamela Rafalow Grossman

  • Open Medical Records: Pros and Cons

    Patients now have full access to their online medical records. What are the benefits and downsides?

    by Jen Tota McGivney

  • Remote Care

    After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.

    by Jon Kelvey

  • Moving Away From the Maximum Tolerated Dose

    The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.

    by Marcus A. Banks

  • The Individual Sphere of Influence

    Can discussion of health inequities lead to actionable change?

    by Marci A. Landsmann

  • A Treatment That Came Just in Time

    Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

    by Laurie Adami

Advertisement

Advertisement

From the AACR

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR